THNR vs. DIVO

Last updated Jun 3, 2026

THNR (Amplify Weight Loss Drug & Treatment ETF) and DIVO (Amplify CWP Enhanced Dividend Income ETF) are both exchange-traded funds - THNR is a Health & Biotech Equities fund tracking the VettaFi Weight Loss Drug & Treatment Index, while DIVO is a Derivative Income fund actively managed by Amplify. THNR is passively managed, while DIVO is actively managed. Over the past year, THNR returned 9.10% vs 19.19% for DIVO. At a 0.48 correlation, their price movements are largely independent. THNR charges 0.59%/yr vs 0.56%/yr for DIVO.

Performance

THNR vs. DIVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Weight Loss Drug & Treatment ETF (THNR) and Amplify CWP Enhanced Dividend Income ETF (DIVO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, THNR achieves a -5.20% return, which is significantly lower than DIVO's 6.11% return.

THNR

• 1D: -1.47%
• 1M: -2.91%
• YTD: -5.20%
• 6M: -3.73%
• 1Y: 9.10%
• 3Y*: —
• 5Y*: —
• 10Y*: —

DIVO

• 1D: 0.48%
• 1M: 1.83%
• YTD: 6.11%
• 6M: 6.82%
• 1Y: 19.19%
• 3Y*: 15.56%
• 5Y*: 10.81%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

THNR vs. DIVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024
THNR Amplify Weight Loss Drug & Treatment ETF	-5.20%	13.65%	-10.36%
DIVO Amplify CWP Enhanced Dividend Income ETF	6.11%	17.40%	6.82%

Correlation

The correlation between THNR and DIVO is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.44
Correlation (All Time) Calculated using the full available price history since May 22, 2024	0.48

THNR vs. DIVO - Sectors Allocation Comparison

Sectors	THNR	DIVO
Healthcare	97.7%	6.7%
Financial Services	0.9%	30.3%
Basic Materials	-	4.1%
Communication Services	-	1.0%
Consumer Cyclical	-	11.6%
Consumer Defensive	-	6.9%
Energy	-	6.8%
Industrials	-	16.2%
Real Estate	-	-
Technology	-	14.5%
Utilities	-	2.0%

Return for Risk

THNR vs. DIVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

THNR

THNR Risk / Return Rank: 16
THNR Sharpe Ratio Rank: 15
THNR Sortino Ratio Rank: 16
THNR Omega Ratio Rank: 15
THNR Calmar Ratio Rank: 18
THNR Martin Ratio Rank: 17

DIVO

DIVO Risk / Return Rank: 66
DIVO Sharpe Ratio Rank: 64
DIVO Sortino Ratio Rank: 69
DIVO Omega Ratio Rank: 62
DIVO Calmar Ratio Rank: 67
DIVO Martin Ratio Rank: 66

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

THNR vs. DIVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Weight Loss Drug & Treatment ETF (THNR) and Amplify CWP Enhanced Dividend Income ETF (DIVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	THNR	DIVO	Difference
Sharpe ratio Return per unit of total volatility	0.48	2.15	-1.68
Sortino ratio Return per unit of downside risk	0.81	3.19	-2.38
Omega ratio Gain probability vs. loss probability	1.10	1.38	-0.29
Calmar ratio Return relative to maximum drawdown	0.76	3.37	-2.61
Martin ratio Return relative to average drawdown	1.75	12.19	-10.45
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

THNR vs. DIVO - Sharpe Ratio Comparison

The current THNR Sharpe Ratio is 0.48, which is lower than the DIVO Sharpe Ratio of 2.15. The chart below compares the historical Sharpe Ratios of THNR and DIVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	THNR	DIVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.48	2.15	-1.68
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.91	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.09	0.85	-0.94

Drawdowns

THNR vs. DIVO - Drawdown Comparison

The maximum THNR drawdown since its inception was -32.51%, which is greater than DIVO's maximum drawdown of -30.04%. Use the drawdown chart below to compare losses from any high point for THNR and DIVO.

Drawdown Indicators

	THNR	DIVO	Difference
Max Drawdown Largest peak-to-trough decline	-32.51%	-30.04%	-2.47%
Max Drawdown (1Y) Largest decline over 1 year	-12.06%	-5.95%	-6.11%
Max Drawdown (3Y) Largest decline over 3 years	—	-12.12%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-13.72%	—
Current Drawdown Current decline from peak	-13.00%	-0.28%	-12.72%
Average Drawdown Average peak-to-trough decline	-12.24%	-2.61%	-9.63%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.26%	1.64%	+3.62%

Volatility

THNR vs. DIVO - Volatility Comparison

Amplify Weight Loss Drug & Treatment ETF (THNR) has a higher volatility of 5.16% compared to Amplify CWP Enhanced Dividend Income ETF (DIVO) at 2.23%. This indicates that THNR's price experiences larger fluctuations and is considered to be riskier than DIVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	THNR	DIVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.16%	2.23%	+2.93%
Volatility (6M) Calculated over the trailing 6-month period	13.55%	6.94%	+6.61%
Volatility (1Y) Calculated over the trailing 1-year period	19.15%	8.97%	+10.18%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.37%	11.93%	+7.44%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.37%	14.84%	+4.53%

THNR vs. DIVO - Expense Ratio Comparison

THNR has a 0.59% expense ratio, which is higher than DIVO's 0.56% expense ratio.

Dividends

THNR vs. DIVO - Dividend Comparison

THNR's dividend yield for the trailing twelve months is around 1.73%, less than DIVO's 6.38% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
DIVO Amplify CWP Enhanced Dividend Income ETF	6.38%	6.44%	4.70%	4.67%	4.76%	4.79%	4.91%	8.16%	5.27%	3.83%
THNR Amplify Weight Loss Drug & Treatment ETF	1.73%	1.64%	0.98%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both THNR and DIVO in my portfolio?

THNR and DIVO have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, THNR or DIVO?

THNR has higher volatility (5.16%) compared to DIVO (2.23%). In terms of maximum drawdown, THNR dropped -32.51% vs DIVO's -30.04%.

Which ETF is better, THNR or DIVO?

On 1-year performance, DIVO leads with 19.19% vs 9.10% for THNR. On fees, DIVO is cheaper at 0.56% per year. On volatility, DIVO has been the lower-risk option at 2.23%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, THNR or DIVO?

Over the 1-year period, DIVO has performed better with a 19.19% return vs 9.10%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, THNR or DIVO?

DIVO is cheaper with a 0.56% expense ratio, compared with 0.59% for THNR.

Which ETF pays a higher dividend yield, THNR or DIVO?

DIVO has the higher dividend yield at 6.38%, compared with 1.73% for THNR.

What is the main difference between THNR and DIVO?

THNR is categorized as Health & Biotech Equities, while DIVO is Derivative Income. Their fees differ too: 0.59% for THNR and 0.56% for DIVO.

Which has better risk-adjusted returns?

DIVO currently has the higher Sharpe Ratio (2.15 vs 0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.